Ambroxol Induces Autophagy and Potentiates Rifampin Antimycobacterial Activity
2018; American Society for Microbiology; Volume: 62; Issue: 9 Linguagem: Inglês
10.1128/aac.01019-18
ISSN1098-6596
AutoresSeong Won Choi, Yuexi Gu, Ryan Peters, Padmini Salgame, Jerrold J. Ellner, Graham S. Timmins, Vojo Deretić,
Tópico(s)Phenothiazines and Benzothiazines Synthesis and Activities
ResumoHost-directed therapy in tuberculosis is a potential adjunct to antibiotic chemotherapy directed at Mycobacterium tuberculosis Ambroxol, a lead compound, emerged from a screen for autophagy-inducing drugs. At clinically relevant doses, ambroxol induced autophagy in vitro and in vivo and promoted mycobacterial killing in macrophages. Ambroxol also potentiated rifampin activity in a murine tuberculosis model.
Referência(s)